Intestinal organoid is a new experimental model and is widely used in research on intestinal diseases and functional changes for its property in replicating structures and functions of organs in vivo. In recent years, researchers have combined gene-editing technology with intestinal organoids, making it possible to study mechanisms of diseases and pertinent treatments for them. This review looks back on the applications of gene-editing in intestinal organoids and their future perspectives in disease modeling and drug developing.